Tesamorelin
Egrifta
Mechanism
Análogo de GHRH que se dirige específicamente al tejido adiposo visceral (IVA) y estimula la liberación de la hormona del crecimiento.
Half-Life
30-40 minutes
Administration
Technical Protocol
Tesamorelin Guide
Tesamorelin is FDA-approved for the treatment of HIV-associated lipodystrophy.
Peer-Reviewed Citations
Tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with abdominal fat accumulation
Falutz J, et al. • N Engl J Med (2007)
Access ResearchFrequently Asked Questions
What is Tesamorelin?
El análogo de GHRH más potente para la reducción de grasa visceral.
How does Tesamorelin work?
Análogo de GHRH que se dirige específicamente al tejido adiposo visceral (IVA) y estimula la liberación de la hormona del crecimiento.
What is the typical dosage of Tesamorelin in research?
The typical research dosage of Tesamorelin is 2 mg (range: 1-2 mg daily). Common administration routes include Subcutaneous.
How should Tesamorelin be stored?
Store at 2-8°C, protect from light
Source Tesamorelin for Your Research
Third-party tested, EU-shipped, certificate of analysis included. High-purity Tesamorelin available from our verified research partner.
Shop TesamorelinRelated Hormonal Peptides
Ipamorelin
A potent and selective growth hormone secretagogue that stimulates growth hormone release.
hormonalCJC-1295 (No DAC)
A modified version of GHRH 1-29, designed to stimulate growth hormone release.
hormonalKisspeptin-10
A key regulator of the reproductive axis.
hormonalOxytocin
The hormone of social connection and maternal bonding.